(Q50523607)

English

Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome--a meta-analysis of randomised trials.

scientific article published on 28 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21466513

0 references

Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome--a meta-analysis of randomised trials. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21466513

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

Neil Johnson

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21466513

publication date

28 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21466513

Australian and New Zealand Journal of Obstetrics and Gynaecology

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21466513

51

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21466513

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21466513

125-129

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21466513

Consensus on infertility treatment related to polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

Consensus on infertility treatment related to polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

Should obese women with polycystic ovary syndrome receive treatment for infertility?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

Obesity, polycystic ovary syndrome, infertility treatment: lifestyle modification is paramount

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01274.X

21 January 2018

Identifiers

10.1111/J.1479-828X.2010.01274.X

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21466513

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21466513

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50523607&oldid=2165569686"